Silverback Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-165,101
Closed -$1.23M 71
2026
Q1
$1.23M Hold
165,101
0.18% 51
2025
Q4
$1.94M Sell
165,101
-36,212
-18% -$391K 0.28% 47
2025
Q3
$1.55M Buy
+201,313
New +$1.41M 0.15% 58

Other funds holding NEO

Silverback Asset Management's NEO Position: Q2 2026 in Review

Silverback Asset Management sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 165,101 shares — an estimated $1.23M sold.

Silverback Asset Management first reported a position in NEO in Q3 2025 and held it in 3 quarters. The position peaked at $1.94M in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Silverback Asset Management reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Silverback Asset Management sold 165,101 NeoGenomics shares in Q2 2026, an estimated $1.23M.
  • Silverback Asset Management first reported a position in NeoGenomics in Q3 2025 and held it in 3 quarters.
  • Silverback Asset Management's NeoGenomics position peaked at $1.94M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Silverback Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.